CannabisNewsBreaks

MondayMar 30, 2020 10:06 am

CannabisNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Announces Receipt of Health Canada License Amendment for Ancaster Processing Facility

The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a leading producer of premium, certified-organic cannabis, today announced its receipt of Health Canada's approval for the licensing of the final component of its Ancaster site, the processing facility. According to the update, the license amendment includes approval of a state-of-the-art production facility designed to support processing activity that includes dedicated spaces for packaging of flower, oils, pre-rolls, and several Cannabis 2.0 products. "Receiving this license amendment was a key element of our 2020 operating plan.  We made significant investments in this state-of-the-art facility, and now that it is fully licensed,…

Continue Reading

FridayMar 27, 2020 2:59 pm

CannabisNewsBreaks – Supreme Cannabis Company Inc.’s (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) New Operating Structure to Boost Efficiencies, Promote Long-Term Growth

Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) continues to grow its portfolio as it identifies new opportunities that align with its mission to cultivate the world’s best cannabis and be recognized as a leader in the global industry. An article discussing the company reads, “To support its plans for long-term growth and to drive efficiencies, Supreme Cannabis Company recently implemented a new operating structure. As part of this new structure, the company has expanded distribution of its 7ACRES brand through an enhanced retail-sales strategy and partnership with humble+fume Inc., one of North America’s leading distributors of cannabis accessories.…

Continue Reading

ThursdayMar 26, 2020 1:23 pm

CannabisNewsBreaks – Plus Products Inc.’s (CSE: PLUS) (OTCQX: PLPRF) Distinguished Leadership Team Positions Company for Success

California-based cannabis-products company Plus Products (CSE: PLUS) (OTCQX: PLPRF) is led by a seasoned leadership team that boasts experience in technology, finance and social media. An article discussing the company reads, “The PLUS leadership team spans a wide range of expertise, work experience and industry exposure. After working at Facebook, CEO Jake Heimark co-founded PLUS. Chief strategy officer Craig Heimark lends high-powered finance expertise to the company gained from his experience at UBS and other similar firms. Managing the company’s finances is CFO Jon Paul, who brings more than 25 years of CFO experience to the team. . . .…

Continue Reading

ThursdayMar 26, 2020 10:01 am

CannabisNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Adapts Operations, Aggressively Reduces Costs While Expanding Product Portfolio

The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a leading producer of premium, certified-organic cannabis, on Wednesday announced that, due to market conditions, it is adapting operations and aggressively reducing costs. According to the update, the company has postponed the startup of its Valleyfield facility in order to centralize cultivation operations at Ancaster. The Ontario facility is able to produce larger volumes than initially anticipated, enabling the company to delay Valleyfield cultivation operations while saving costs and capital. “Multiple factors, most particularly the COVID-19 pandemic, are contributing to an environment in which we must be extremely prudent with how…

Continue Reading

WednesdayMar 25, 2020 11:19 am

CannabisNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496) Appoints Ernst & Young 2018 Entrepreneur of the Year in Health Care to Special Advisory Committee

Champignon Brands (CSE: SHRM) (OTC: SHRMF) (FWB: 496), a health and wellness company specializing in the formulation of a suite of medicinal mushroom health products, as well as novel delivery platforms for the pharmaceutical and nutraceutical industries, today announced the appointment of Dr. Joseph Gabriele, a molecular pharmacologist specializing in signal transduction within the central nervous system, to its Special Advisory Committee. According to the update, Dr. Gabriele, PhD, specializes in the areas of molecular pharmacology, transdermal delivery and formulation chemistry with pharmaceutical, natural molecules and will champion the company’s development and commercialization of rapid onset treatments capable of improving…

Continue Reading

WednesdayMar 25, 2020 9:58 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) to Webcast Live at March 26 Life Sciences Investor Forum

Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, on Tuesday announced that its Chief Executive Officer, Chris Bunka, will present live at LifeSciencesInvestorForum.com on March 26. According to the update, Bunka’s presentation is scheduled to begin at 12:00 PM ET. The live, interactive online event invites investors to ask the company questions in real-time. It is suggested that interested parties pre-register and run the online system check to expedite participation and receive event updates. An archived webcast will be made available after the event for those unable to join live on the day of the…

Continue Reading

TuesdayMar 24, 2020 10:05 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) to Participate in Life Sciences Investor Forum’s Virtual Conference

Life Sciences Investor Forum today announced the schedule for its inaugural event for both public and private companies, investors and worldwide industry professionals. The one-day event is kicking off on Thursday, March 26 with the first live webcast at 9:30 AM ET. Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, is scheduled to provide a presentation at 12:00 PM ET on March 26. Per the release, pre-registration is recommended for investors and it is encouraged that they run the online system check to expedite participation and receive event updates. There is no cost to view…

Continue Reading

TuesdayMar 24, 2020 9:51 am

CannabisNewsBreaks – No Borders, Inc.’s (NBDR) MediDent Supplies Announces New Stay at Home 15 Minute Rapid Result COVID-19 Blood Tests

No Borders (OTC: NBDR) on Monday announced that the Company has executed an agreement with its existing suppliers in Hong Kong to bring its 15 minute “At Home” Serological COVID-19 test to the USA. According to the update, the brand new “MediDent Supplies 15 Minute Rapid Result Covid-19 Test” is being manufactured by a MediDent Supplies partner with existing U.S. FDA registrations for both the manufacturer and the serological test kit itself. MediDent Supplies is actively engaged with the FDA to obtain an Emergency Use Authorization for its COVID-19 blood test and believes it will receive expedited approval due to…

Continue Reading

MondayMar 23, 2020 12:55 pm

CannabisNewsBreaks – Champignon Brands Inc. (CSE: SHRM) CEO Shares Strategic Goals in Exclusive Audio Interview

Champignon Brands (CSE: SHRM), a wellness company specializing in medicinal mushroom and mushroom-infused products, today announced the broadcast of its audio interview with NetworkNewsAudio (“NNA”), one of 40+ brands in the InvestorBrandNetwork (“IBN”). In the interview, Champignon Brands CEO Gareth Birdsall joins NNW’s Stuart Smith to delve into the company’s strategic plan to expand its portfolio and become a preeminent player in the emerging psychedelic medicine arena. “We’ve achieved some pretty impressive sales from around the globe, revamped our e-commerce website, as well as commenced certain research and development initiatives,” Birdsall said, noting Champignon recently completed an initial public offering…

Continue Reading

MondayMar 23, 2020 11:51 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Announces Expansion of Pharmaceutical Division to Include Lipophilic Antiviral Active Molecules for COVID-19 Treatment

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, today announced expansion of the scope and activities of its 100%-owned subsidiary Lexaria Pharmaceutical Corp. According to the update, Lexaria Pharmaceutical will investigate how the company’s patented DehydraTECH(TM) drug delivery technology could enhance delivery and effectiveness of certain antiviral drugs in the fight against coronavirus disease COVID-19. Lexaria intends to expand collaboration with leading laboratories across North America and internationally as soon as possible. To view the full press release, visit http://cnw.fm/4NW8h About Lexaria Lexaria Bioscience Corp. is a global innovator in drug delivery platforms. Its…

Continue Reading